Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Jesper Bonde; Jeppe Bennekou Schroll; Bettina Kjær Kristensen; Elsebeth Lynge; Maria Waldstrøm; Berit Andersen

Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Jesper Bonde^*, Jeppe Bennekou Schroll, Bettina Kjær Kristensen, Elsebeth Lynge, Maria Waldstrøm, Berit Andersen

^*Corresponding author af dette arbejde

Center for Epidemiologisk Forskning

Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

Abstract

Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

Bidragets oversatte titel	Phased implementation of HPV-based cervical cancer screening in Denmark
Originalsprog	Dansk
Artikelnummer	V04210327
Sider (fra-til)	1518-1522
Antal sider	5
Tidsskrift	Ugeskrift for laeger
Vol/bind	184
Udgave nummer	16
Status	Udgivet - 28 feb. 2022

Adgang til dokumentet

https://ugeskriftet.dk/videnskab/differentieret-implementering-af-hpv-baseret-screening-i-dansk-livmoderhalskraeftscreening

Citationsformater

Bonde, J., Schroll, J. B., Kristensen, B. K., Lynge, E., Waldstrøm, M., & Andersen, B. (2022). Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening. Ugeskrift for laeger, 184(16), 1518-1522. ???articleNumberLabel??? V04210327. https://ugeskriftet.dk/videnskab/differentieret-implementering-af-hpv-baseret-screening-i-dansk-livmoderhalskraeftscreening

@article{487cb7109ab24d9eac08701c930a310c,

title = "Differentieret implementering af HPV-baseret screening i dansk livmoderhalskr{\ae}ftscreening",

abstract = "Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.",

author = "Jesper Bonde and Schroll, {Jeppe Bennekou} and Kristensen, {Bettina Kj{\ae}r} and Elsebeth Lynge and Maria Waldstr{\o}m and Berit Andersen",

year = "2022",

month = feb,

day = "28",

language = "Dansk",

volume = "184",

pages = "1518--1522",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "16",

}

TY - JOUR

T1 - Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

AU - Bonde, Jesper

AU - Schroll, Jeppe Bennekou

AU - Kristensen, Bettina Kjær

AU - Lynge, Elsebeth

AU - Waldstrøm, Maria

AU - Andersen, Berit

PY - 2022/2/28

Y1 - 2022/2/28

N2 - Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

AB - Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

M3 - Review

C2 - 35244023

SN - 0041-5782

VL - 184

SP - 1518

EP - 1522

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 16

M1 - V04210327

ER -

Differentieret implementering af HPV-baseret screening i dansk livmoderhalskræftscreening

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater